Fox Jonathan C

Director at Edgewise Therapeutics, Inc. · on record since Apr 3, 2026
Chief Medical Officer at MyoKardia Inc · on record since Oct 28, 2015
See Remarks at Eidos Therapeutics, Inc. · on record since Jun 19, 2018

Insider trading activity of Fox Jonathan C

Transactions on record: 60; since Nov 5, 2015

Open-market buys: 3; $330.4K

Open-market sells: 31; $7.3M

Companies traded: 3; last filing Jul 1, 2026

Figures computed from official regulatory filings — methodology.

Companies where Fox Jonathan C has traded

Edgewise Therapeutics, Inc.13 tx · $300.4K · Jul 1, 2026
Eidos Therapeutics, Inc.45 tx · $7.3M · Jan 28, 2021
MyoKardia Inc2 tx · $45.4K · May 6, 2016

Track record of Fox Jonathan C

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Fox Jonathan C

Co-insiders of Fox Jonathan C

Semigran MarcEdgewise Therapeutics, Inc. +1
AGARWAL SUNILMyoKardia Inc
AGUIAR ERICEidos Therapeutics, Inc.
Bauer JakeMyoKardia Inc
Blaustein RobertEdgewise Therapeutics, Inc.
Brege LauraEdgewise Therapeutics, Inc.
BridgeBio Pharma LLCEidos Therapeutics, Inc.

This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →

Company	Filed	Type	Qty	Price	Value · USD	Src
Edgewise Therapeutics, Inc.	Jul 1, 2026	Award	319	0.00 USD	—	SEC
Edgewise Therapeutics, Inc.	Jun 16, 2026	AwardD	16,377	0.00 USD	$0	SEC
Edgewise Therapeutics, Inc.	Apr 3, 2026	Award	339	0.00 USD	$0	SEC
Edgewise Therapeutics, Inc.	Jan 5, 2026	Award	473	0.00 USD	$0	SEC
Edgewise Therapeutics, Inc.	Nov 13, 2025	Buy	10,700	18.64 USD	$199.4K	SEC
Edgewise Therapeutics, Inc.	Oct 2, 2025	Award	728	0.00 USD	$0	SEC
Edgewise Therapeutics, Inc.	Jul 2, 2025	Award	858	0.00 USD	$0	SEC
Edgewise Therapeutics, Inc.	Jun 18, 2025	AwardD	30,000	0.00 USD	$0	SEC
Edgewise Therapeutics, Inc.	Apr 3, 2025	Award	559	0.00 USD	$0	SEC
Edgewise Therapeutics, Inc.	Jun 12, 2024	AwardD	20,594	0.00 USD	$0	SEC
Edgewise Therapeutics, Inc.	Dec 28, 2023	Buy	10,857	9.30 USD	$101K	SEC
Edgewise Therapeutics, Inc.	Jun 14, 2023	AwardD	22,123	0.00 USD	$0	SEC
Edgewise Therapeutics, Inc.	Mar 7, 2023	AwardD	43,731	0.00 USD	$0	SEC
Eidos Therapeutics, Inc.	Jan 28, 2021	Other	-380,467	—	—	SEC
Eidos Therapeutics, Inc.	Jan 28, 2021	Gift	-500	0.00 USD	$0	SEC
Eidos Therapeutics, Inc.	Jan 28, 2021	OtherD	-70,000	—	—	SEC
Eidos Therapeutics, Inc.	Sep 18, 2020	Sell	-5,767	50.16 USD	$289.3K	SEC
Eidos Therapeutics, Inc.	Sep 16, 2020	Sell	-111	50.00 USD	$5.6K	SEC
Eidos Therapeutics, Inc.	Sep 16, 2020	Sell	-1,000	50.06 USD	$50.1K	SEC
Eidos Therapeutics, Inc.	Sep 16, 2020	Sell	-3,122	50.16 USD	$156.6K	SEC
Eidos Therapeutics, Inc.	Jul 9, 2020	Sell	-5,000	50.00 USD	$250K	SEC
Eidos Therapeutics, Inc.	Jul 1, 2020	Other	1,088	0.00 USD	$0	SEC
Eidos Therapeutics, Inc.	Jun 5, 2020	Gift	-1,020	0.00 USD	$0	SEC
Eidos Therapeutics, Inc.	Jun 5, 2020	Sell	-5,000	50.00 USD	$250K	SEC
Eidos Therapeutics, Inc.	Jun 5, 2020	Gift	-1,020	0.00 USD	$0	SEC

Company	Filed	Type	Qty	Price	Value · USD	Src
Edgewise Therapeutics, Inc.	Jul 1, 2026	Award	319	0.00 USD	—	SEC
Edgewise Therapeutics, Inc.	Jun 16, 2026	AwardD	16,377	0.00 USD	$0	SEC
Edgewise Therapeutics, Inc.	Apr 3, 2026	Award	339	0.00 USD	$0	SEC
Edgewise Therapeutics, Inc.	Jan 5, 2026	Award	473	0.00 USD	$0	SEC
Edgewise Therapeutics, Inc.	Nov 13, 2025	Buy	10,700	18.64 USD	$199.4K	SEC
Edgewise Therapeutics, Inc.	Oct 2, 2025	Award	728	0.00 USD	$0	SEC
Edgewise Therapeutics, Inc.	Jul 2, 2025	Award	858	0.00 USD	$0	SEC
Edgewise Therapeutics, Inc.	Jun 18, 2025	AwardD	30,000	0.00 USD	$0	SEC
Edgewise Therapeutics, Inc.	Apr 3, 2025	Award	559	0.00 USD	$0	SEC
Edgewise Therapeutics, Inc.	Jun 12, 2024	AwardD	20,594	0.00 USD	$0	SEC
Edgewise Therapeutics, Inc.	Dec 28, 2023	Buy	10,857	9.30 USD	$101K	SEC
Edgewise Therapeutics, Inc.	Jun 14, 2023	AwardD	22,123	0.00 USD	$0	SEC
Edgewise Therapeutics, Inc.	Mar 7, 2023	AwardD	43,731	0.00 USD	$0	SEC
Eidos Therapeutics, Inc.	Jan 28, 2021	Other	-380,467	—	—	SEC
Eidos Therapeutics, Inc.	Jan 28, 2021	Gift	-500	0.00 USD	$0	SEC
Eidos Therapeutics, Inc.	Jan 28, 2021	OtherD	-70,000	—	—	SEC
Eidos Therapeutics, Inc.	Sep 18, 2020	Sell	-5,767	50.16 USD	$289.3K	SEC
Eidos Therapeutics, Inc.	Sep 16, 2020	Sell	-111	50.00 USD	$5.6K	SEC
Eidos Therapeutics, Inc.	Sep 16, 2020	Sell	-1,000	50.06 USD	$50.1K	SEC
Eidos Therapeutics, Inc.	Sep 16, 2020	Sell	-3,122	50.16 USD	$156.6K	SEC
Eidos Therapeutics, Inc.	Jul 9, 2020	Sell	-5,000	50.00 USD	$250K	SEC
Eidos Therapeutics, Inc.	Jul 1, 2020	Other	1,088	0.00 USD	$0	SEC
Eidos Therapeutics, Inc.	Jun 5, 2020	Gift	-1,020	0.00 USD	$0	SEC
Eidos Therapeutics, Inc.	Jun 5, 2020	Sell	-5,000	50.00 USD	$250K	SEC
Eidos Therapeutics, Inc.	Jun 5, 2020	Gift	-1,020	0.00 USD	$0	SEC